OVAGEN — 20MG

Ovagen is a short-chain peptide bioregulator marketed within the Khavinson cytomedin / cytogen peptide tradition — a class of low molecular weight peptide compounds proposed to function through tissue-specific gene expression modulation. Unlike the major characterized Khavinson peptides (Epithalon, Cortagen, Pinealon, Chonluten) which have defined sequences published in the Russian academic literature, Ovagen is a less rigorously characterized peptide preparation described as ovarian tissue-derived. The compound is investigated in preclinical research as a representative of the broader peptide bioregulator class for tissue-specific short-peptide pharmacology research and is studied alongside other cytomedin-class compounds in comparative Khavinson SAR investigations. Because the specific sequence of “Ovagen” is not well-documented in published Western scientific literature, researchers working with this compound should verify the specific chemistry against the supplier’s Certificate of Analysis (COA) and rely on the MS-verified molecular weight as the primary identity confirmation.